David Hallal, Director at iTeos Therapeutics, Inc. (ITOS), sold 50,000 shares at $43.57 ($2.2M) on 2021-12-20, disclosed to the SEC on 2021-12-22.
Open-market sale of $2.2M ITOS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ITOS | SELL | 2025-06-06 | $2.3M | — | Filing → |
| ALVR | SELL | 2022-10-21 | $5.1M | — | Filing → |
| ALVR | SELL | 2022-09-30 | $2.9M | — | Filing → |